COM:SUTROBIO
Sutro Biopharma, Inc.
- Stock
Last Close
2.53
22/11 21:00
Market Cap
294.46M
Beta: -
Volume Today
822.21K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | -5.83M - | -5.83M 0% | |||||||
average payables | 3.15M - | 2.98M 5.29% | 4.32M 44.98% | 5.56M 28.72% | 8.44M 51.61% | 22.07M 161.69% | 21.13M 4.27% | ||
average receivables | 1.10M - | 2.06M 86.87% | 4.39M 113.64% | 5.93M 34.94% | 9.01M 51.92% | 9.79M 8.68% | 21.60M 120.68% | ||
book value per share | -12.99 - | -15.58 19.91% | 22.84 246.63% | 4.26 81.35% | 10.19 139.33% | 5.48 46.28% | 4.28 21.89% | 2.49 41.85% | |
capex per share | -0.63 - | -0.47 24.53% | -0.27 42.95% | -0.15 43.92% | -0.22 44.35% | -0.33 51.81% | -0.15 53.39% | -0.07 53.69% | |
capex to depreciation | -0.78 - | -0.66 14.37% | -0.34 48.38% | -0.73 112.43% | -1.66 127.67% | -3.16 90.67% | -1.38 56.34% | -0.63 54.16% | |
capex to operating cash flow | 0.33 - | 0.09 73.23% | -0.12 237.25% | 0.05 143.61% | 0.11 96.40% | 0.19 78.42% | -2.21 1,280.25% | 0.04 101.75% | |
capex to revenue | -0.07 - | -0.06 12.88% | -0.04 36.76% | -0.08 100.99% | -0.17 104.86% | -0.25 48.39% | -0.12 53.18% | -0.03 75.79% | |
cash per share | 6.79 - | 3.15 53.66% | 35.51 1,028.39% | 5.13 85.54% | 11.30 120.15% | 4.29 62.02% | 6.59 53.54% | 6.24 5.26% | |
days of inventory on hand | |||||||||
days payables outstanding | 505.52 - | ||||||||
days sales outstanding | 3.53 - | 11.46 224.92% | 23.65 106.41% | 53.79 127.47% | 47.49 11.70% | 73.46 54.67% | 38.36 47.79% | 85.66 123.32% | |
debt to assets | 0.05 - | 0.36 679.77% | 0.07 81.62% | 0.06 4.29% | 0.08 34.06% | 0.17 98.49% | 0.17 1.28% | 0.34 104.35% | |
debt to equity | -0.04 - | -0.13 282.69% | 0.11 183.38% | 0.10 9.78% | 0.10 0.50% | 0.23 126.06% | 0.31 36.93% | 1.07 242.85% | |
dividend yield | |||||||||
earnings yield | 0.02 - | -0.19 1,256.76% | -0.68 267.30% | -0.22 67.53% | -0.05 76.81% | -0.16 209.32% | -0.29 83.61% | -0.41 42.30% | |
enterprise value | 94.77M - | 98.97M 4.44% | -58.63M 159.24% | 257.46M 539.14% | 525.56M 104.13% | 713.21M 35.70% | 430.23M 39.68% | 371.58M 13.63% | |
enterprise value over ebitda | 12.87 - | -7.03 154.60% | 2.01 128.62% | -5.52 374.64% | -8.05 45.84% | -7.66 4.89% | -3.43 55.24% | -4.51 31.43% | |
ev to operating cash flow | -7.21 - | -2.67 62.95% | -4.62 73.16% | -3.96 14.34% | -7.75 95.77% | -8.73 12.65% | 121.23 1,488.32% | -3.33 102.75% | |
ev to sales | 1.59 - | 1.91 20.57% | -1.53 179.78% | 6.02 494.78% | 12.30 104.20% | 11.53 6.31% | 6.35 44.92% | 2.42 61.93% | |
free cash flow per share | -2.51 - | -5.77 130.18% | 1.93 133.47% | -2.98 254.44% | -2.30 22.90% | -2.10 8.57% | -0.08 95.96% | -1.93 2,168.99% | |
free cash flow yield | -0.16 - | -0.38 130.18% | 0.21 156.40% | -0.27 226.64% | -0.11 60.94% | -0.14 33.40% | -0.01 92.56% | -0.45 4,173.53% | |
graham net net | -16.04 - | -18.08 12.75% | 19.93 210.20% | 2.79 86.01% | 9.52 241.63% | 2.57 73.04% | 2.84 10.50% | 1.36 52.21% | |
graham number | 8.43 - | 31.40 272.44% | 56.14 78.77% | 15.25 72.83% | 15.97 4.67% | 17.04 6.72% | 15.04 11.75% | 9.97 33.72% | |
income quality | -7.73 - | 1.88 124.37% | -0.36 119.07% | 1.17 424.81% | 2.11 80.92% | 0.77 63.33% | -0.03 103.85% | 1.05 3,610.50% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -31.49 - | -22.93 27.17% | -12.75 44.40% | -17.43 36.68% | -31.41 80.20% | -38.54 22.70% | 7.10 118.43% | ||
interest debt per share | 0.46 - | 2.18 378.08% | 2.84 30.28% | 0.62 78.17% | 1.15 85.52% | 1.31 14.14% | 1.40 6.44% | 2.44 74.98% | |
inventory turnover | |||||||||
invested capital | -0.04 - | -0.13 282.69% | 0.11 183.38% | 0.10 9.78% | 0.10 0.50% | 0.23 126.06% | 0.31 36.93% | 1.07 242.85% | |
market cap | 106.36M - | 106.36M 0% | 51.95M 51.16% | 252.54M 386.18% | 707.17M 180.02% | 686.25M 2.96% | 409.97M 40.26% | 258.10M 37.04% | |
net current asset value | -110.49M - | -124.14M 12.35% | 118.35M 195.33% | 69.99M 40.86% | 316.12M 351.68% | 129.67M 58.98% | 119.57M 7.79% | 100.45M 15.99% | |
net debt to ebitda | -1.57 - | 0.52 133.31% | 3.79 623.30% | -0.11 102.78% | 2.78 2,739.19% | -0.29 110.40% | -0.16 44.24% | -1.38 752.34% | |
net income per share | 0.24 - | -2.81 1,256.76% | -6.13 117.96% | -2.43 60.41% | -1.11 54.22% | -2.36 112.00% | -2.35 0.30% | -1.78 24.45% | |
operating cash flow per share | -1.88 - | -5.30 181.87% | 2.20 141.57% | -2.83 228.60% | -2.08 26.51% | -1.77 14.92% | 0.07 103.95% | -1.86 2,752.35% | |
payables turnover | 0.72 - | ||||||||
receivables turnover | 103.52 - | 31.86 69.22% | 15.44 51.55% | 6.79 56.04% | 7.69 13.26% | 4.97 35.35% | 9.52 91.52% | 4.26 55.22% | |
research and ddevelopement to revenue | 0.73 - | 1.06 44.84% | 1.41 33.75% | 1.54 8.70% | 1.80 17.34% | 1.69 6.34% | 2.02 19.97% | 1.17 42.01% | |
return on tangible assets | 0.02 - | -0.48 2,065.63% | -0.16 67.23% | -0.36 125.24% | -0.09 74.23% | -0.32 246.50% | -0.29 7.98% | -0.23 22.55% | |
revenue per share | 8.54 - | 7.39 13.38% | 6.67 9.78% | 1.86 72.10% | 1.31 29.54% | 1.34 2.30% | 1.34 0.45% | 2.56 91.30% | |
roe | -0.02 - | 0.18 1,064.67% | -0.27 248.65% | -0.57 112.31% | -0.11 80.87% | -0.43 294.63% | -0.55 27.64% | -0.71 29.94% | |
roic | -0.01 - | 0.21 1,521.62% | -0.28 233.44% | -0.52 84.05% | -0.22 57.47% | -0.30 35.29% | -0.41 39.38% | -0.32 21.66% | |
sales general and administrative to revenue | 0.25 - | 0.32 27.57% | 0.56 75.85% | 0.76 37.04% | 0.86 13.00% | 0.91 5.02% | 0.88 2.92% | 0.41 53.66% | |
shareholders equity per share | -12.99 - | -15.58 19.91% | 22.84 246.63% | 4.26 81.35% | 10.19 139.33% | 5.48 46.28% | 4.28 21.89% | 2.49 41.85% | |
stock based compensation to revenue | 0.02 - | 0.03 65.89% | 0.07 178.06% | 0.24 222.78% | 0.28 15.60% | 0.38 34.64% | 0.39 3.34% | 0.16 58.25% | |
tangible asset value | -90.90M - | -109.00M 19.91% | 131.54M 220.68% | 97.79M 25.66% | 332.05M 239.56% | 252.56M 23.94% | 217.05M 14.06% | 149.65M 31.05% | |
tangible book value per share | -12.99 - | -15.58 19.91% | 22.84 246.63% | 4.26 81.35% | 10.19 139.33% | 5.48 46.28% | 4.28 21.89% | 2.49 41.85% | |
working capital | -493K - | -6.33M 1,183.37% | 173.52M 2,842.58% | 95.60M 44.91% | 348.58M 264.62% | 176.78M 49.29% | 170M 3.83% | 327.80M 92.82% |
All numbers in (except ratios and percentages)